Perth biotechology firm Solbec Pharmaceuticals Ltd is seeking to remove a big "overhang" of options, offering holders of the instruments shares in the company to reduce the almost 150 million options on issue.

Perth biotechology firm Solbec Pharmaceuticals Ltd is seeking to remove a big "overhang" of options, offering holders of the instruments shares in the company to reduce the almost 150 million options on issue.